Skip to main content
TipRanks
Go Ultimate75% OFF

Helix BioPharma (HBP) Ownership - Who Owns Helix BioPharma?

32 Followers

Helix BioPharma (HBP) Ownership Overview

  • 9.88% Insiders
  • 90.12% Public Companies and Individual Investors

The ownership structure of Helix BioPharma (TSE:HBP) stock is a mix of institutional, retail, and individual investors. , 9.88% is owned by Insiders, and 90.12% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Oct 07, 2026Jerzy WilczewskiC$1,040,000
Aug 10, 2026Jerzy WilczewskiC$1,500,000
Aug 10, 2026Jerzy WilczewskiC$1,536,421
Aug 10, 2026Jerzy WilczewskiC$2,490,000

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

TSE:HBP top shareholders
Holder# of SharesType% HoldingValue
Jerzy Wilczewski7,548,986Insider9.88%4,491,647

FAQ

What percentage of Helix BioPharma (TSE:HBP) stock is held by retail investors?
According to the latest TipRanks data, approximately 90.12% of Helix BioPharma (TSE:HBP) stock is held by public companies and individual investors.
Who owns the most shares of Helix BioPharma (TSE:HBP)?
Jerzy Wilczewski owns the most shares of Helix BioPharma (TSE:HBP).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.